WebNovacyt is an innovative high growth diagnostic group of companies founded in 2005 and focused on the design, manufacture and supply of a growing portfolio of oncology and infectious disease diagnostic products. They are passionate about their business and the healthcare industry sector they work with and would like to thank you for your ... WebNOVACYT has raised a total of $37.8M in funding over 7 rounds. Their latest funding was raised on May 30, 2024 from a Post-IPO Debt round. NOVACYT is registered under the …
NOVACYT - Funding, Financials, Valuation & Investors - CrunchBase
WebMay 30, 2024 · See Novacyt funding rounds, investors, investments, exits and more. Evaluate their financials based on Novacyt's post-money valuation and revenue. WebNovacyt SA Graham Mullis, Chief Executive Officer James McCarthy, Chief Financial Officer +44 (0)1276 600081 SP Angel Corporate Finance LLP (Nominated Adviser and Broker) Matthew Johnson / Charlie Bouverat (Corporate Finance) Vadim Alexandre / Rob Rees (Corporate Broking) +44 (0)20 3470 0470 Numis Securities Limited (Joint Broker) ramblaz vetement tom\\u0026co
Novacyt - Products, Competitors, Financials, Employees, …
WebMar 31, 2024 · Novacyt SA NYZ Ownership Morningstar Rating Rating as of Mar 6, 2024 Quote Chart Stock Analysis News Price vs Fair Value Sustainability Trailing Returns … WebNOVACYT : Press releases relating to NOVACYT Investor relations Börse Stuttgart: NYZ Börse Stuttgart WebInvestors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ... driving book pdf jamaica